| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/02/1998 | CA2275540A1 Cerebellum and embryo specific protein |
| 07/02/1998 | CA2275436A1 Treatment of mammalian myocardium with morphogen locally, or with morphogenically-treated myogenic precursor cells |
| 07/02/1998 | CA2274675A1 Vegf-b/receptor complex and uses thereof |
| 07/02/1998 | CA2274586A1 Methods for detecting and inhibiting the rna component of telomerase |
| 07/02/1998 | CA2219265A1 Human cardiac/brain tolloid-like protein |
| 07/01/1998 | EP0850251A1 Nitrosated hemoglobins and therapeutic uses therefor |
| 07/01/1998 | EP0850240A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
| 07/01/1998 | EP0850067A1 Method for treating cancers using 6- 3- 1-adamantyl]-4-hydroxyphenyl] |
| 07/01/1998 | EP0850063A1 Methods and compositions for treating fungal infections in mammals |
| 07/01/1998 | EP0850056A1 Topical anti-skin-cancer preparations |
| 07/01/1998 | EP0850055A2 Protein tyrosine kinase inhibitors for treating osteoarthritis |
| 07/01/1998 | EP0850054A1 Formulations of haloalkylamines and local anaesthetics and methods for the treatment of reflex sympathetic dystrophy (rsd) |
| 07/01/1998 | EP0850050A1 Oral fast-dissolving compositions for dopamine agonists |
| 07/01/1998 | EP0850046A2 Microemulsions for use as vehicles for administration of active compounds |
| 07/01/1998 | EP0691972B1 FURO 3,2-b]PYRIDINES AND THIENO 3,2-b]PYRIDINES AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS |
| 07/01/1998 | CN1186515A 转化生长因子αHI Transforming growth factor αHI |
| 07/01/1998 | CN1186502A Compositions and methods for inhibiting thrombogenesis |
| 07/01/1998 | CN1186501A Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4 |
| 07/01/1998 | CN1186495A Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
| 07/01/1998 | CN1186440A Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant |
| 07/01/1998 | CN1186439A Platelet-specific chimeric immunoglobulin and methods of use therefor |
| 07/01/1998 | CN1186434A Pharmaceutical composition comprising proteinase inhibitor and monoglyceride |
| 07/01/1998 | CN1186431A Compositions and methods using nitroxides in combination with biocompatible macromolecules |
| 06/30/1998 | US5773580 Human protein kinase c inhibitor homolog |
| 06/30/1998 | US5773570 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 06/30/1998 | US5773479 Atherosclerosis, tamoxifen |
| 06/30/1998 | US5773478 Composition comprising methylphenidate and another drug |
| 06/30/1998 | US5773457 Compositions |
| 06/30/1998 | US5773438 Synthetic matrix metalloprotease inhibitors and use thereof |
| 06/30/1998 | US5773436 Use of serotonin antagonists for treating fibromyalgia |
| 06/30/1998 | US5773427 Prevention of fiber-induced intestinal gas production by chitosan |
| 06/30/1998 | US5773424 Parasiticide |
| 06/30/1998 | US5773292 Ablate or kill cancer cells |
| 06/30/1998 | US5773231 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| 06/30/1998 | US5773209 Prevention of formation of oxidized polyunsaturated fatty acid, suppression of gene expression through redox sensitive pathways |
| 06/30/1998 | US5773023 Enhanced skin penetration system for improving topical delivery of drugs |
| 06/30/1998 | US5773004 Compositions for curing diabetes mellitus, processes for the preparation of same, and usage of same |
| 06/30/1998 | US5772999 Method of preventing, countering, or reducing NSAID-induced gastrointestinal damage by administering milk or egg products from hyperimmunized animals |
| 06/30/1998 | US5772997 Monoclonal antibodies directed to the HER2 receptor |
| 06/25/1998 | WO1998027208A1 NOVEL FELINE Fc EPSILON RECEPTOR ALPHA CHAIN NUCLEIC ACID MOLECULES, PROTEINS AND USES THEREOF |
| 06/25/1998 | WO1998027113A2 Melanocortin derivatives for specific binding of melanocortin receptor 3, 4 or 5 |
| 06/25/1998 | WO1998026773A1 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing |
| 06/25/1998 | WO1998026770A2 The topical use of kappa opioid agonists to treat ocular pain |
| 06/25/1998 | WO1998022100A3 New use for 1,3-propanediol derivatives |
| 06/25/1998 | WO1998019649A3 Methods and compositions for inhibition of angiogenesis |
| 06/25/1998 | WO1998017268A3 Method of alleviating pain by means of combining tramadol with an nmda antagonist |
| 06/25/1998 | WO1998012220A3 Novel tumor proteins |
| 06/25/1998 | WO1998010068A3 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals |
| 06/25/1998 | WO1998001154A3 Treatment and diagnosis of infections of gram positive cocci |
| 06/25/1998 | DE19654079A1 Endo-ekto-parasitizide Mittel Endo-ecto-parasiticidal agent |
| 06/25/1998 | CA2275442A1 Melanocortin derivatives for specific binding of melanocortin receptor 3, 4 or 5 |
| 06/25/1998 | CA2264692A1 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing |
| 06/24/1998 | EP0848948A1 Long-lasting composition for rectal administration |
| 06/24/1998 | EP0848736A1 Acid resistant calcium carbonate composition containing an aluminum salt and uses therefor |
| 06/24/1998 | EP0848720A2 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers |
| 06/24/1998 | EP0848613A1 Analogs for specific oligosaccharide-neuregulin interactions and uses thereof |
| 06/24/1998 | EP0848592A1 Antistress agents for aquatic animals |
| 06/24/1998 | CN1185319A Tumor-blood-vessel growth inhibitor and medicinal composition |
| 06/23/1998 | US5770612 Administering substituted benzothiophenes, solvates or salts along with analgesics, diuratics or antihistaminesalong with |
| 06/23/1998 | US5770610 Melatonin agonists for use in the treatment of benign prostatic hyperplasia (BPH) |
| 06/23/1998 | US5770593 Method of determining a pharmaceutical combination preparations for use in anti-neoplastic therapy |
| 06/23/1998 | US5770582 Mixture of deoxycytidine and deoxyguanosine in a carrier |
| 06/23/1998 | US5770571 Method and agents for inhibiting protein aging |
| 06/23/1998 | US5770384 Method for determining compound interaction with E2 binding proteins |
| 06/23/1998 | US5770233 Container filled with infusion liquids and infusion preparation |
| 06/23/1998 | US5770209 Acceleration of wound healing using connective tissue growth factor |
| 06/23/1998 | US5770197 Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules |
| 06/23/1998 | US5770196 Modified antibody variable domains and therapeutic uses thereof |
| 06/23/1998 | US5770195 Antitumor |
| 06/18/1998 | WO1998026077A1 USE OF A VECTOR EXPRESSING DNA POLYMERASE β AS MEDICINE |
| 06/18/1998 | WO1998026069A1 Methods and compositions for identifying morphogen analogs |
| 06/18/1998 | WO1998026068A1 Human apoptosis-related calcium-binding protein |
| 06/18/1998 | WO1998026067A1 Adipocyte-specific differentiation-related protein |
| 06/18/1998 | WO1998026050A2 Glutathionylspermidine synthetase |
| 06/18/1998 | WO1998026047A1 Methods and compositions for identifying morphogen analogs |
| 06/18/1998 | WO1998025964A1 Submucosa extracts |
| 06/18/1998 | WO1998025956A2 Human gtp-binding proteins |
| 06/18/1998 | WO1998025950A1 Polyprolyl inhibitors of cyclophilin |
| 06/18/1998 | WO1998025645A1 Therapeutic applications of antigens or epitopes associated with impaired cellular peptide processing, e.g. expressed on rma-s cells transfected with a b7-1 gene |
| 06/18/1998 | WO1998025640A2 Novel methods for testing inhibitors of paired helical filaments and uses for treatment of alzheimer's disease |
| 06/18/1998 | WO1998025637A1 Biomaterial derived from vertebrate liver tissue |
| 06/18/1998 | WO1998025623A1 Methods and compositions for preventing and treating bone loss |
| 06/18/1998 | WO1998025621A1 Improved pharmaceutical compositions |
| 06/18/1998 | WO1998025618A1 Use of nucleosides, nucleobases, and their derivatives for reduction of toxic side effects of cytostatic agents |
| 06/18/1998 | WO1998025612A1 Novel therapeutic application of pyrrole derivatives |
| 06/18/1998 | WO1998025601A1 Fibrinogen receptor antagonists |
| 06/18/1998 | WO1998025598A2 Methods and pharmaceutical compositions for inhibiting tumour cell growth |
| 06/18/1998 | WO1998025597A2 Method for treating and preventing heart failure and ventricular dilatation |
| 06/18/1998 | WO1998025469A1 The use of cd4-binding small molecules to inhibit immune responses |
| 06/18/1998 | WO1998006386A3 Derivates from bisaryltetracarbonacid, and pharmarceutical product containing them |
| 06/18/1998 | CA2274837A1 Therapeutic applications of antigens or epitopes associated with impaired cellular peptide processing, e.g. expressed on rma-s cells transfected with a b7-1 gene |
| 06/18/1998 | CA2274739A1 Human apoptosis-related calcium-binding protein |
| 06/18/1998 | CA2274735A1 Human gtp-binding proteins |
| 06/18/1998 | CA2274728A1 Adipocyte-specific differentiation-related protein |
| 06/18/1998 | CA2274604A1 The use of cd4-binding small molecules to inhibit immune responses |
| 06/18/1998 | CA2274515A1 Glutathionylspermidine synthetase |
| 06/18/1998 | CA2274029A1 Fibrinogen receptor antagonists |
| 06/18/1998 | CA2263886A1 Method for treating and preventing heart failure and ventricular dilatation |
| 06/18/1998 | CA2263828A1 Polyprolyl inhibitors of cyclophilin |
| 06/17/1998 | EP0847279A1 Antipruriginous cosmetic and/or pharmaceutical compositions consisting of one or several light local anaesthetics and one or several astringent substances |